Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2019-A02475-52 | Other Identifier | ID RCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Clinical pharmacy is a patient-centered discipline and improves significantly the safety of drug management. Regarding medications, clinical pharmacy is efficient. The investigator hypothesize that clinical pharmacy applied to medical devices could be as effective as in the medication field.
The main objective of this study is to assess the effectiveness of clinical pharmacy activities during entire care pathways of patients implanted with a PICC line, in preventing complications.
This is a preliminary, before-after, monocentric and prospective study. The study will begin with an observational period and will be followed by an experimental intervention period. Sixty-nine adult patients in each period will be included. During the observational phase, no clinical pharmacy activities will be performed. During the interventional phase, clinical pharmacists will be active during the entire patients' care pathways.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| control | No Intervention | patients for the observational phase. This corresponds to usual cares where no clinical pharmacy activities will be performed | |
| Interventional | Experimental | patients for the interventional phase where clinical pharmacy activities will be performed at each step of the care pathway: from hospitalization to home care. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Clinical pharmacy activities along the care pathways | Other | PICC line implantation: Optimize the logistics circuit of the PICC line by rationalizing orders through the evaluation of potential losses. Ensure the due traceability of the implanted medical device. Discharge order : Analysis, optimization and pharmaceutical interventions if necessary Discharge Pharmaceutical Interview : Discussion with the patient, Information about the PICC line maintenance and associated therapies, Information about the prescribed drugs. Call to the community pharmacist to transfer the patient's prescription. Follow-up calls for 3 months after discharge
|
| Measure | Description | Time Frame |
|---|---|---|
| Assessment of the number of complications during the interventional phase. | Number of complications per patient and per month in each group. Number of complications per patient and per month in each group | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of consultations and rehospitalizations post-discharge. | Rates of consultations and rehospitalizations in each group. | 3 months |
| Acceptance rate of pharmaceutical interventions (PI) during interventional phase and evaluation of PIs' criticality. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Charlotte ROUZAUD LABORDE | : Institute of metabolic and cardiac diseases (I2MC), Inserm 1048 unit. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CIVADE | Toulouse | Occitanie | 31000 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33827827 | Derived | Pouget AM, Civade E, Cestac P, Rouzaud-Laborde C. From hospitalisation to primary care: integrative model of clinical pharmacy with patients implanted with a PICC line-research protocol for a prospective before-after study. BMJ Open. 2021 Apr 7;11(4):e039490. doi: 10.1136/bmjopen-2020-039490. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Number of potentially inappropriate prescriptions resulting in an accepted PI over total of PIs. |
| 3 months |
| Conformity analysis of the PICC line logistic circuit | Number of correct items over total (items checklist about stock, supply chain, traceability) | day 0 |
| Conformity analysis of treatment indication. | Number of correct items over total (items checklist about recommended indications, implantation duration, etc.) | day 0 |
| Conformity analysis of hospital prescriptions issued in town. | Conformity rates per phase. | day 0 |
| Patient's Quality Of Life assessment | EQ-5D-5L score | at discharge |
| Patient's Quality Of Life assessment | EQ-5D-5L score | 3 months |
| Participants satisfaction survey | Assessment of patients' satisfactions regarding their therapeutic management | 3 months |
| healthcare professionals satisfaction survey | assessment of healthcare professionals' satisfactions regarding their collaboration with the pharmacists | 3 months |
| Direct hospital costs. | description and evaluation of the direct medical costs | 3 months |